Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >>

Pharma & Healthcare

>>

United States Recombinant Vaccine Market


United States Recombinant Vaccine Market Report 2018

Report code: SDMRPH4818 | Industry: Pharma & Healthcare | Published On: 3/2/2018


In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Vaccine in these regions, from 2013 to 2025 (forecast).

United States Recombinant Vaccine market competition by top manufacturers/players, with Recombinant Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co., Inc.
Green Cross Corporation
Pfizer, Inc.
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc
Novartis AG
Bharat Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Human
Animal

If you have any special requirements, please let us know and we will offer you the report as you want.

Table  of  Contents

United  States  Recombinant  Vaccine  Market  Report  2018
1  Recombinant  Vaccine  Overview
        1.1  Product  Overview  and  Scope  of  Recombinant  Vaccine
        1.2  Classification  of  Recombinant  Vaccine  by  Product  Category
                1.2.1  United  States  Recombinant  Vaccine  Market  Size  (Sales  Volume)  Comparison  by  Type  (2013-2025)
                1.2.2  United  States  Recombinant  Vaccine  Market  Size  (Sales  Volume)  Market  Share  by  Type  (Product  Category)  in  2017
                1.2.3  Subunit  Recombinant  Vaccines
                1.2.4  Attenuated  Recombinant  Vaccines
                1.2.5  Vector  Recombinant  Vaccines
        1.3  United  States  Recombinant  Vaccine  Market  by  Application/End  Users
                1.3.1  United  States  Recombinant  Vaccine  Market  Size  (Consumption)  and  Market  Share  Comparison  by  Application  (2013-2025)
                1.3.2  Human
                1.3.3  Animal
        1.4  United  States  Recombinant  Vaccine  Market  by  Region
                1.4.1  United  States  Recombinant  Vaccine  Market  Size  (Value)  Comparison  by  Region  (2013-2025)
                1.4.2  The  West  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
                1.4.3  Southwest  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
                1.4.4  The  Middle  Atlantic  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
                1.4.5  New  England  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
                1.4.6  The  South  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
                1.4.7  The  Midwest  Recombinant  Vaccine  Status  and  Prospect  (2013-2025)
        1.5  United  States  Market  Size  (Value  and  Volume)  of  Recombinant  Vaccine  (2013-2025)
                1.5.1  United  States  Recombinant  Vaccine  Sales  and  Growth  Rate  (2013-2025)
                1.5.2  United  States  Recombinant  Vaccine  Revenue  and  Growth  Rate  (2013-2025)

2  United  States  Recombinant  Vaccine  Market  Competition  by  Players/Suppliers
        2.1  United  States  Recombinant  Vaccine  Sales  and  Market  Share  of  Key  Players/Suppliers  (2013-2018)
        2.2  United  States  Recombinant  Vaccine  Revenue  and  Share  by  Players/Suppliers  (2013-2018)
        2.3  United  States  Recombinant  Vaccine  Average  Price  by  Players/Suppliers  (2013-2018)
        2.4  United  States  Recombinant  Vaccine  Market  Competitive  Situation  and  Trends
                2.4.1  United  States  Recombinant  Vaccine  Market  Concentration  Rate
                2.4.2  United  States  Recombinant  Vaccine  Market  Share  of  Top  3  and  Top  5  Players/Suppliers
                2.4.3  Mergers  &  Acquisitions,  Expansion  in  United  States  Market
        2.5  United  States  Players/Suppliers  Recombinant  Vaccine  Manufacturing  Base  Distribution,  Sales  Area,  Product  Type

3  United  States  Recombinant  Vaccine  Sales  (Volume)  and  Revenue  (Value)  by  Region  (2013-2018)
        3.1  United  States  Recombinant  Vaccine  Sales  and  Market  Share  by  Region  (2013-2018)
        3.2  United  States  Recombinant  Vaccine  Revenue  and  Market  Share  by  Region  (2013-2018)
        3.3  United  States  Recombinant  Vaccine  Price  by  Region  (2013-2018)

4  United  States  Recombinant  Vaccine  Sales  (Volume)  and  Revenue  (Value)  by  Type  (Product  Category)  (2013-2018)
        4.1  United  States  Recombinant  Vaccine  Sales  and  Market  Share  by  Type  (Product  Category)  (2013-2018)
        4.2  United  States  Recombinant  Vaccine  Revenue  and  Market  Share  by  Type  (2013-2018)
        4.3  United  States  Recombinant  Vaccine  Price  by  Type  (2013-2018)
        4.4  United  States  Recombinant  Vaccine  Sales  Growth  Rate  by  Type  (2013-2018)

5  United  States  Recombinant  Vaccine  Sales  (Volume)  by  Application  (2013-2018)
        5.1  United  States  Recombinant  Vaccine  Sales  and  Market  Share  by  Application  (2013-2018)
        5.2  United  States  Recombinant  Vaccine  Sales  Growth  Rate  by  Application  (2013-2018)
        5.3  Market  Drivers  and  Opportunities

6    United  States  Recombinant  Vaccine  Players/Suppliers  Profiles  and  Sales  Data
        6.1  Merck  &  Co.,  Inc.
                6.1.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.1.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.1.2.1  Product  A
                        6.1.2.2  Product  B
                6.1.3  Merck  &  Co.,  Inc.  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.1.4  Main  Business/Business  Overview
        6.2  Green  Cross  Corporation
                6.2.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.2.2.1  Product  A
                        6.2.2.2  Product  B
                6.2.3  Green  Cross  Corporation  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.2.4  Main  Business/Business  Overview
        6.3  Pfizer,  Inc.
                6.3.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.3.2.1  Product  A
                        6.3.2.2  Product  B
                6.3.3  Pfizer,  Inc.  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.3.4  Main  Business/Business  Overview
        6.4  Sanofi  S  A.
                6.4.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.4.2.1  Product  A
                        6.4.2.2  Product  B
                6.4.3  Sanofi  S  A.  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.4.4  Main  Business/Business  Overview
        6.5  Protein  Science  Corporation
                6.5.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.5.2.1  Product  A
                        6.5.2.2  Product  B
                6.5.3  Protein  Science  Corporation  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.5.4  Main  Business/Business  Overview
        6.6  GlaxoSmithKline  Plc
                6.6.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.6.2.1  Product  A
                        6.6.2.2  Product  B
                6.6.3  GlaxoSmithKline  Plc  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.6.4  Main  Business/Business  Overview
        6.7  Novartis  AG
                6.7.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.7.2.1  Product  A
                        6.7.2.2  Product  B
                6.7.3  Novartis  AG  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.7.4  Main  Business/Business  Overview
        6.8  Bharat  Biotech
                6.8.2  Recombinant  Vaccine  Product  Category,  Application  and  Specification
                        6.8.2.1  Product  A
                        6.8.2.2  Product  B
                6.8.3  Bharat  Biotech  Recombinant  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.8.4  Main  Business/Business  Overview

7  Recombinant  Vaccine  Manufacturing  Cost  Analysis
        7.1  Recombinant  Vaccine  Key  Raw  Materials  Analysis
                7.1.1  Key  Raw  Materials
                7.1.2  Price  Trend  of  Key  Raw  Materials
                7.1.3  Key  Suppliers  of  Raw  Materials
                7.1.4  Market  Concentration  Rate  of  Raw  Materials
        7.2  Proportion  of  Manufacturing  Cost  Structure
                7.2.1  Raw  Materials
                7.2.2  Labor  Cost
                7.2.3  Manufacturing  Expenses
        7.3  Manufacturing  Process  Analysis  of  Recombinant  Vaccine

8  Industrial  Chain,  Sourcing  Strategy  and  Downstream  Buyers
        8.1  Recombinant  Vaccine  Industrial  Chain  Analysis
        8.2  Upstream  Raw  Materials  Sourcing
        8.3  Raw  Materials  Sources  of  Recombinant  Vaccine  Major  Manufacturers  in  2017
        8.4  Downstream  Buyers

9  Marketing  Strategy  Analysis,  Distributors/Traders
        9.1  Marketing  Channel
                9.1.1  Direct  Marketing
                9.1.2  Indirect  Marketing
                9.1.3  Marketing  Channel  Development  Trend
        9.2  Market  Positioning
                9.2.1  Pricing  Strategy
                9.2.2  Brand  Strategy
                9.2.3  Target  Client
        9.3  Distributors/Traders  List

10  Market  Effect  Factors  Analysis
        10.1  Technology  Progress/Risk
                10.1.1  Substitutes  Threat
                10.1.2  Technology  Progress  in  Related  Industry
        10.2  Consumer  Needs/Customer  Preference  Change
        10.3  Economic/Political  Environmental  Change

11  United  States  Recombinant  Vaccine  Market  Size  (Value  and  Volume)  Forecast  (2018-2025)
        11.1  United  States  Recombinant  Vaccine  Sales  Volume,  Revenue  Forecast  (2018-2025)
        11.2  United  States  Recombinant  Vaccine  Sales  Volume  Forecast  by  Type  (2018-2025)
        11.3  United  States  Recombinant  Vaccine  Sales  Volume  Forecast  by  Application  (2018-2025)
        11.4  United  States  Recombinant  Vaccine  Sales  Volume  Forecast  by  Region  (2018-2025)

12  Research  Findings  and  Conclusion

13  Appendix
        13.1  Methodology/Research  Approach
                13.1.1  Research  Programs/Design
                13.1.2  Market  Size  Estimation
                13.1.3  Market  Breakdown  and  Data  Triangulation
        13.2  Data  Source
                13.2.1  Secondary  Sources
                13.2.2  Primary  Sources
        13.3  Disclaimer


List of Tables and Figures

Figure Product Picture of Recombinant Vaccine
Figure United States Recombinant Vaccine Market Size (K Doses) by Type (2013-2025)
Figure United States Recombinant Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Subunit Recombinant Vaccines Product Picture
Figure Attenuated Recombinant Vaccines Product Picture
Figure Vector Recombinant Vaccines Product Picture
Figure United States Recombinant Vaccine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Recombinant Vaccine by Application in 2017
Figure Human Examples
Table Key Downstream Customer in Human
Figure Animal Examples
Table Key Downstream Customer in Animal
Figure United States Recombinant Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Recombinant Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Vaccine Sales Share by Players/Suppliers
Figure United States Recombinant Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Recombinant Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Vaccine Revenue Share by Players/Suppliers
Table United States Market Recombinant Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Recombinant Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Recombinant Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Vaccine Product Category
Table United States Recombinant Vaccine Sales (K Doses) by Region (2013-2018)
Table United States Recombinant Vaccine Sales Share by Region (2013-2018)
Figure United States Recombinant Vaccine Sales Share by Region (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Region in 2017
Table United States Recombinant Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Region (2013-2018)
Figure United States Recombinant Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Recombinant Vaccine Revenue Market Share by Region in 2017
Table United States Recombinant Vaccine Price (USD/Dose) by Region (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) by Type (2013-2018)
Table United States Recombinant Vaccine Sales Share by Type (2013-2018)
Figure United States Recombinant Vaccine Sales Share by Type (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Type in 2017
Table United States Recombinant Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Recombinant Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type in 2017
Table United States Recombinant Vaccine Price (USD/Dose) by Types (2013-2018)
Figure United States Recombinant Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Recombinant Vaccine Sales (K Doses) by Application (2013-2018)
Table United States Recombinant Vaccine Sales Market Share by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Market Share by Application in 2017
Table United States Recombinant Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Recombinant Vaccine Sales Growth Rate by Application (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Green Cross Corporation Basic Information List
Table Green Cross Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofi S A. Basic Information List
Table Sanofi S A. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Protein Science Corporation Basic Information List
Table Protein Science Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis AG Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Novartis AG Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Novartis AG Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales Growth Rate (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales Market Share in United States (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Vaccine
Figure Manufacturing Process Analysis of Recombinant Vaccine
Figure Recombinant Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Recombinant Vaccine
Table Distributors/Traders List
Figure United States Recombinant Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Recombinant Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Recombinant Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT